Filing Details
- Accession Number:
- 0001225208-16-032725
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-05-06 09:51:40
- Reporting Period:
- 2016-05-04
- Filing Date:
- 2016-05-06
- Accepted Time:
- 2016-05-06 09:51:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 78003 | Pfizer Inc | PFE | Pharmaceutical Preparations (2834) | 135315170 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1263544 | Sally Susman | Pfizer Inc.-Corp. Secretary 235 East 42Nd St. New York NY 10017 | Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-05-04 | 20,100 | $22.28 | 195,951 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-05-04 | 300 | $33.86 | 195,651 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-05-04 | 400 | $33.87 | 195,251 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-05-04 | 1,042 | $33.88 | 194,209 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-05-04 | 8,358 | $33.89 | 185,851 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-05-04 | 10,000 | $33.85 | 175,851 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2016-05-05 | 56,016 | $22.28 | 231,867 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-05-05 | 10,920 | $33.72 | 220,947 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-05-05 | 18,676 | $33.71 | 202,271 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-05-05 | 26,420 | $33.70 | 175,851 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2016-05-04 | 20,100 | $0.00 | 20,100 | $22.28 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2016-05-05 | 56,016 | $0.00 | 56,016 | $22.28 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 79,900 | 2011-02-28 | 2018-02-28 | No | 4 | M | Direct |
| 23,884 | 2011-02-28 | 2018-02-28 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 600 | Indirect | By Rule 16b-3 Plan |
Billionaire Hedge Funds
